DRF-1042

• Description:

  DRF-1042, an orally active camptothecin analog, exhibits anticancer and insecticidal activities by inhibiting DNA topoisomerase I. It has been studied for its efficacy against solid tumors, including prostate and colon cancers.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  408.4

• Molecular Formula:

  C22H20N2O6

• Notes:

  Research use only, not for human use.

• Receptor:

  Topoisomerase

• CAS Number:

  200619-13-2